CA
NZ
UK
AU
IND
US
SunCoke Energy (NYSE:SXC) filed its quarterly report for the period ended Sept. 30 on Tuesday. Sales and other operating revenue were USD 485.9 million, compared with USD 487.0 million. Lower volumes after the shutdown of the Haverhill I cokemaking facility and the pass-through of …
TransUnion (NYSE:TRU) reported third quarter 2026 results on Tuesday. Revenue was USD 1,312 million, up 12% and 8% on an organic constant currency basis. Net income attributable to TransUnion was USD 156 million, compared with USD 97 million, and diluted EPS was USD 0.81 …
Travel + Leisure Co. (NYSE:TNL) reported third quarter 2026 results on Tuesday. Net revenues were USD 1.101 billion, up from USD 1.044 billion. Vacation ownership interest sales rose to USD 545 million from USD 494 million, service and membership fees were USD 408 million, …
UPS (NYSE:UPS) reported third quarter 2026 results on Tuesday. Consolidated revenue rose 6.7% to USD 22.9 billion. Operating profit was USD 1.7 billion for a 7.6% margin, and adjusted operating profit was USD 2.1 billion for a 9.0% margin. Diluted EPS was USD 1.37, …
Watsco (NYSE:WSO) reported third quarter 2026 results on Tuesday. Revenues rose 7% to a record USD 2.22 billion, with same-store sales up 4%. Gross profit rose 3% to a record USD 586 million, and gross margin was 26.4%, or 26.5% on a same-store basis, …
Wave Life Sciences (NASDAQ:WVE) filed its quarterly report for the period ended Sept. 30 on Tuesday. The clinical-stage biotechnology company develops RNA medicines on its PRISM platform, which combines RNA interference, RNA editing, antisense silencing and splicing modalities.
Xylem (NYSE:XYL) reported third quarter 2026 results on Tuesday. Revenue was USD 2,201 million, compared with USD 2,268 million, and flat organically. Management attributed the flat revenue to project timing and a more cautious, deliberate utility spending environment. Orders rose 10% organically to USD …
Zura Bio (NASDAQ:ZURA), a clinical-stage biotech company developing medicines for autoimmune and inflammatory diseases, filed its quarterly report for the period ended Sept. 30 on Tuesday. Total operating expenses were USD 28.8 million, compared with USD 19.5 million. Research and development expense rose 63%, …
Alkami Technology (NASDAQ:ALKT) reports third-quarter results on Wednesday, Oct. 28, after the market closes. Consensus stands at EPS of 0.20 on revenue of USD 133.54 million, and the company has a market capitalization of USD 1.68 billion.
Alerus Financial (NASDAQ:ALRS) reports third-quarter results on Wednesday, Oct. 28, with the timing not given in the estimates table. Consensus stands at EPS of 0.66 on revenue of USD 76.72 million, and the company has a market capitalization of USD 810.64 million.
Please wait processing your request...